Reply to Ganesan et al

J Infect Dis. 2012 Feb 1;205(3):518-9. doi: 10.1093/infdis/jir758. Epub 2011 Nov 28.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Acquired Immunodeficiency Syndrome / mortality*
  • Antigens, CD*
  • HIV Infections / drug therapy*
  • HIV-1 / drug effects*
  • Heptanoic Acids / pharmacology*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology*
  • Lymphocyte Activation*
  • Male
  • Pyrroles / pharmacology*
  • RNA, Viral / blood*
  • RNA, Viral / drug effects*
  • Receptors, CCR5 / physiology*
  • Receptors, CXCR4 / physiology*
  • T-Lymphocytes / immunology*

Substances

  • Antigens, CD
  • Heptanoic Acids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyrroles
  • RNA, Viral
  • Receptors, CCR5
  • Receptors, CXCR4